Bornaprine

Bornaprine
Clinical data
Trade names Sormodren
AHFS/Drugs.com International Drug Names
Routes of
administration
By mouth (tablets)
ATC code N04AA11 (WHO)
Legal status
Legal status
  • ℞ (Prescription only)
Pharmacokinetic data
Protein binding 96%
Metabolism Extensive
Excretion Urine (mainly)[1]
Identifiers
CAS Number 20448-86-6 26908-91-8
PubChem (CID) 30160
ChemSpider 28011 YesY
UNII 9M363FGA7J YesY
KEGG D07302
ChEMBL CHEMBL2104596
ECHA InfoCard 100.205.286
Chemical and physical data
Formula C21H31NO2
Molar mass 329.476 g/mol
3D model (Jmol) Interactive image
  (verify)

Bornaprine (brand name Sormodren) is an anticholinergic used as an antiparkinsonian agent.[2][3]

References

  1. "Sormodren Tabletten" (PDF) (in German). BGP Products Ges.m.b.H. Perfektastraße 84A, 1230 Wien. Retrieved 30 August 2016.
  2. Cantello, R.; Riccio, A.; Gilli, M.; Delsedime, M.; Scarzella, L.; Aguggia, M.; Bergamasco, B. (1986). "Bornaprine vs placebo in Parkinson disease: Double-blind controlled cross-over trial in 30 patients". Italian journal of neurological sciences. 7 (1): 139–143. doi:10.1007/BF02230432. PMID 3514543.
  3. Jasek, W, ed. (2007). Austria-Codex (in German) (62nd ed.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-181-4.



This article is issued from Wikipedia - version of the 8/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.